The frequency of BRAF mutations in the current study seems to be among the higher previously reported mutation rates [46–48], but is still lower than the mutation rate reported by Illei et al. [26] (6.3%), who analyzed 1006 lung cancers with NGS. The gene discussed is BRAF; the disease is lung carcinoma.